Connect with us

Hi, what are you looking for?

Saturday, Apr 11, 2026

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "blood cancer"

Enliven Therapeutics stock climbs on upgrades, sector validation from Merck acquisition

Enliven Therapeutics stock climbs on upgrades, sector validation from Merck acquisition

Medical and Pharmaceutical

Enliven Therapeutics stock climbs on upgrades, sector validation from Merck acquisition

Enliven Therapeutics is a clinical-stage biotech company focused on developing targeted cancer drugs

Joseph MortonMarch 26, 2026

Icahn Researchers Target Lysosomes to Reverse Stem Cell Aging

Icahn Researchers Target Lysosomes to Reverse Stem Cell Aging

Medical and Pharmaceutical

Icahn researchers target lysosomes to reverse stem cell aging

The research focused on hematopoietic stem cells, often called HSCs

Joseph MortonFebruary 26, 2026

More Posts